CRISPR Therapeutics (NASDAQ:CRSP) inventory has been falling over the previous month. With none milestone bulletins because it gained its second U.S. regulatory approval for its CASGEVY program in January, traders…
Tag:
CRISPR Therapeutics (NASDAQ:CRSP) inventory has been falling over the previous month. With none milestone bulletins because it gained its second U.S. regulatory approval for its CASGEVY program in January, traders…